ライフサイエンスコーパス: allo-

1 Bilateral intra-hippocampal infusion of ALLO (0.1 microg/side) was anticonvulsant, increasing th

2 ALLO (3alpha5alpha and 3alpha5beta isomers) binds with h

3 osphates accepted by E(p) to include alpha-d-allo-, alpha-d-altro-, and alpha-d-talopyranosyl phospha

4 allows a rationalization of the inability of allo-, altro-, and glucopyranosyl-based oligonucleotides

5 of antibodies against type II collagen (both allo- and autoantibodies) were measured.

6 were significantly elevated in patients with allo- and autoantibody-mediated thrombocytopenias compar

7 In contrast, both allo- and autograft recipients had glucagon responses to

8 CD177 presents antigens in allo- and autoimmune diseases on the neutrophil surface.

9 n monocytes and macrophages participating in allo- and autoimmune reactions, including the perivascul

10 ss has been made in clarifying mechanisms of allo- and autoimmune responses to FVIII and in suppressi

11 that tolerance strategies should target both allo- and autoimmune responses to prevent this process.

12 that lung allograft rejection involves both allo- and autoimmune responses, and graft destruction th

13 B cells participate in the priming of the allo- and autoimmune responses, and their depletion can

14 n down-modulate T cell response and suppress allo- and autoimmune responses.

15 aftment of encapsulated murine beta-cells in allo- and autoimmune settings.

16 ransplants seems unlikely to be explained by allo- and autoimmune-mediated mechanisms alone and in a

17 nclude that allogeneic HSC transplants block allo- and autoimmunity, despite residual host T-cell pre

18 with no effect on IL-10 production, for both allo- and autologous T cell proliferation.

19 ium borohydride and then deprotected to give allo- and epi-inositol in good yield that confirmed the

20 and immunostimulatory capacity in presenting allo- and islet-associated antigens by NF-kappaB ODN DC

21 P-10) were expressed at equivalent levels in allo- and isografts for 2-4 days posttransplant and then

22 unctional differences by MSC in responses to allo- and recall Ags, we examined whether MSC could exer

23 no difference in precursor frequency between allo- and xeno-reactive CD4+ CD25+ FoxP3 high cells.

24 Further investigation on allo- and xenoantibody cross-reactivity is required.

25 ic surface phenotype and efficiently present allo- and xenoantigens to allogeneic T cells after co-cu

26 nfluences endothelial-mediated activation of allo- and xenogeneic immune cells.

27 precursor and primary foetal grafts in both allo- and xenograft environments using several labelling

28 ons such as inflammation, chronic arthritis, allo- and xenograft rejection.

29 Cardiac and renal allo- and xenografts can become naturally resistant to v

30 e in the immune response against solid organ allo- and xenografts.

31 The expansion and precursor frequencies of allo- and xenoreactive Tregs were assessed by labeling w

32 e use of baboons as a model for the study of allo- and xenotransplantation has become increasingly im

33 ideration when analyzing immune responses to allo- and xenotransplantation in baboons.

34 n, will offer insight into new therapies for allo- and xenotransplantation.

35 The novel, recently described allo (antigen)-specific CD154+T cells were evaluated for

36 The concentration of ALLO ( approximately 40 fmol/ml in each CSF fraction of

37 glycoprotein complex is a favored target for allo-, auto-, and drug-dependent antibodies associated w

38 SCID into hyperglycemic NOD), and in a mixed allo-/autoimmune setting (BALB/c into hyperglycemic NOD)

39 ring analogues in descending order was KAC > ALLO > MAC, with increments similar to the biphenyl comp

40 We adoptively transferred allo-(H-2d)-reactive Tcl or Tc2 cells from H-2b mice int

41 eic hematopoietic stem cell transplantation (allo- HSCT) t(8;21) (q22;q22) acute myeloid leukemia pat

42 Whereas allogeneic (allo-)MSCs are immunoevasive, the capacity of CSCs to si

43 eminent, with "other" inositols (cis-, epi-, allo-, muco-, neo-, L-chiro-, D-chiro-, and scyllo-) and

44 rty-seven patients were randomized to either allo- or auto-hMSCs in a 1:1 ratio.

45 let destruction is most frequently caused by allo- or autoantibodies via Fcgamma receptor-dependent p

46 ial to inhibit undesired immune responses to allo- or autoantigens.

47 for those that could mount the most vigorous allo- or autoimmune responses, or perhaps become toleran

48 two classes and whether WGD results from an allo- or autopolyploid event is inconsistent with recent

49 cies based on defined meiotic parameters for allo- or autotetraploid species with a gametophytic S-Z

50 ain expected values for for diploid and for (allo- or autotetraploidy SI grasses.

51 s donors and recipients for orthotopic liver allo- or iso-graft transplants.

52 suppressive agent for reversing the onset of allo- or possibly autoimmune attacks against pancreatic

53 occur physiologically as a result of chronic allo- or self-antigen stimulation.

54 ciated peptides that have been identified as allo- or xenoantigens is consistent with this hypothesis

55 n CD8+ T cells elicit a vigorous response to allo- or xenogeneic MHC class I molecules.

56 a given MHC-bound peptide to the responding allo- or xenoreactive T cell repertoire is not clear.